Long-Term Follow-up of Radiofrequency to Articular Branches of the Femoral and Obturator Nerve in Chronic Hip Pain

December 25, 2024 updated by: SINEM SARI, Aydin Adnan Menderes University

Long-Term Follow-up of the Effect of Conventional Radiofrequency Thermocoagulation Application to the Articular Branches of the Femoral and Obturator Nerve on Pain and Functional Capacity in Patients With Chronic Hip Pain

It has been observed that the deterioration in the physical performance of the hip, the medical need before the specialist consultation and the deterioration in the health status can progress treatment[3]. When conservative treatment methods such as physical therapy and weight change, the use of walking aids (such as a cane) and analgesic agents are used, these interruptions usually provide short-term and partial benefits. After the application of medical treatment procedures, hip prostheses are usually separated. However, the additional diseases of the patients, the fact that the surgery is a major surgery and the mortality rate is high, and the life of the prostheses used are limited have led to the search for alternative pain palliation.

Hip joint radiofrequency thermocoagulation is a procedure performed in our clinic. In this study, we aimed to examine the long-term effects of hip RFT on pain and functional capacity changes in patients.

Study Overview

Detailed Description

After obtaining hospital ethics committee approval, it was planned to retrospectively examine adult patients over the age of 18 who applied to the outpatient clinic of the Department of Algology, ADÜTF, between May 2021 and September 2023 and who underwent elective conventional radiofrequency thermocoagulation (RFT) procedure to the articular branches of the femoral and obturator nerves due to chronic hip pain. The prospective studies conducted in our clinic titled "Treatment of chronic hip pain with conventional radiofrequency thermocoagulation to the articular branches of the femoral and obturator nerve" and "Comparison of Conventional Radiofrequency Thermocoagulation to the Articular Branches of the Femoral and Obturator Nerve in Chronic Hip Pain with Intra-Articular Steroid Injection and Pericapsular Nerve Group (PENG) Block" (theses of assistants Sevilay Şimşek Karaoğlu and Bilge Ergün, respectively) will include patients who underwent conventional RF. In the studies, patients who underwent elective conventional radiofrequency thermocoagulation (RFT) to the articular branches of the femoral and obturator nerve were followed up for up to 6 months. The follow-up of the patients in our clinic is ongoing. In our study, the long-term follow-up of these patients will be evaluated retrospectively at 12 months and 24 months.

Study Type

Observational

Enrollment (Estimated)

76

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Aydın, Turkey, 09100
        • Adnan Menderes University, Research hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients who underwent conventional RF will be included in the prospective studies titled "Treatment of chronic hip pain with conventional radiofrequency thermocoagulation to the articular branches of the femoral and obturator nerves" and "Comparison of conventional radiofrequency thermocoagulation to the articular branches of the femoral and obturator nerves with intra-articular steroid injection and pericapsular nerve group (PENG) block in chronic hip pain" (theses of assistant Sevilay Şimşek Karaoğlu and Bilge Ergün, respectively) conducted in our clinic.

Description

Inclusion Criteria:

  1. Being over 18 years of age
  2. Having received written consent
  3. Those with chronic hip pain lasting longer than 3 weeks

Exclusion Criteria:

  1. Major psychiatric disease
  2. Patients with lumbar pressure pain or referred pain
  3. Patients using anticoagulant agents
  4. Patients with infection in the area to be treated
  5. Those with local anesthetic allergy
  6. Those with betamethasone allergy
  7. Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
RFT
Conventional radiofrequency thermocoagulation (RFT) procedure was applied to the femoral and obturator nerve joint branches electively due to chronic hip pain.
İt is a pain intensity determination system based on the system where there person tells a point between 0=(no pain) 10=( unbearable pain) and to describe their pain
It includes 24 questions under three sub-headings as pain, stiffness and physical function

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
chronic pain assessment
Time Frame: 12 month, 24 month
Pain will be assessed with the SAS (Verbal Pain Score) score before surgery, at 12 and 24 months.
12 month, 24 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
functional capacity assesment
Time Frame: 12 month, 24 month
Functional capacity will be assessed with the womac score before surgery, at 12 and 24 months.
12 month, 24 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 5, 2025

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

April 20, 2025

Study Registration Dates

First Submitted

December 23, 2024

First Submitted That Met QC Criteria

December 25, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 25, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Hip Pain

Clinical Trials on VPS (Verbal Pain Score)

Subscribe